Skip to content
zameds

Mometasone furoate

Sold as Elica, Elomet, Nasonex, Rinelon, Uniclar, Asmanex twisthaler, Momate, Mometasone sandoz nasal, Zilfone nasal, Monact, Naxal aqueous nasal, Momagex, Mometasone adco, Mometasone glenmark, Nexomist, Nasomist, Aspen mometasone, Mometagen, Elocon

S4Read from the PI-PIL document and verified
Loading the molecular structure
C27H30Cl2O6521.40 g/mol

[(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate

Drag to rotate. Structure from PubChem CID 441336.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
9
Registrations
26
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Organon South Africa (Pty) Ltd1 of 14 cancelledElica, Elomet, Nasonex, Rinelon, Uniclar, Asmanex twisthaler, Eloconcream, ointment, lotion, 100 mg, 200 ug, 400 ug310544, 310545, 310546, 310547, 310590, 310591, 320157, 330482, 330483, 340343, 340344, V0272, V0273, X0266Not determinedPIPIL
Activo Health (Pty) LtdMomateointment440095Not determinedNone
Sandoz South Africa (Pty) LtdMometasone sandoz nasal, Zilfone nasalspray460490, 460491.49Not determinedNone
Cipla Medpro (Pty) Ltd1 of 3 cancelledMonact, Nexomist, NasomistNot stated471223, A380341, A380342Not determinedNone
Austell Pharmaceuticals (Pty) LtdCancelledNaxal aqueous nasalspray510005Not determinedNone
Adcock ingram limitedMomagex, Mometasone adcoNot stated530167, 530168.167Not determinedNone
Glenmark Pharmaceuticals South Africa (Pty) LtdMometasone glenmark50 μg530614Not determinedNone
Pharmacare limited û woodmeadCertificate held by Pharmacare limitedAspen mometasone1,0 mg/1,0 gA380668S4PIPIL
Viatris Healthcare (Pty) LtdCancelledMometagen0,1 %A400666Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Elica cream

EACH 1 g CREAM CONTAINS MOMETASONE FUROATE 1,0 mg

Cream31054431/13.4.1/0544RegisteredNot determinedNone
Elica ointment

EACH 1 g OINTMENT CONTAINS MOMETASONE FUROATE 1,0 mg

Ointment31054531/13.4.1/0545RegisteredNot determinedNone
Elomet cream

EACH 1 g OF CREAM CONTAINS MOMETASONE FUROATE 1,0 mg

Cream31054631/13.4.1/0546RegisteredNot determinedNone
Elomet ointment

EACH 1,0 g OINTMENT CONTAINS MOMETASONE FUROATE 1,0 mg

Ointment31054731/13.4.1/0547RegisteredNot determinedNone
Elica lotion

EACH 1 g OF LOTION CONTAINS MOMETASONE FUROATE 1,0 mg

Lotion31059031/13.4.1/0590RegisteredNot determinedNone
Elomet lotion

EACH 1,0 g LOTION CONTAINS MOMETASONE FUROATE 1,0 mg

Lotion31059131/13.4.1/0591RegisteredNot determinedNone
Nasonex

EACH METERED-DOSE CONTAINS MOMETASONE FUROATE 50,0 ug

100 mgAqueous nasal spray32015732/21.5.1/0157Approved 19 January 2018RegisteredNot determinedPIPIL
Rinelon

EACH METERED DOSE CONTAINS MOMETASONE FUROATE 50,0 ug

100 mgAqueous nasal spray33048233/21.5.1/0482Approved 19 January 2018RegisteredNot determinedPIPIL
Uniclar

EACH METERED DOSE CONTAINS MOMETASONE FUROATE 50,0 ug

Not listed33048333/21.5.1/0483RegisteredNot determinedNone
Asmanex twisthaler 200 ug

EACH UNIT DOSE CONTAINS MOMETASONE FUROATE 200,0 ug

200 ug34034334/21.5.1/0343CancelledNot determinedNone
Asmanex twisthaler 400 ug

EACH UNIT DOSE CONTAINS MOMETASONE FUROATE 400,0 ug

400 ug34034434/21.5.1/0344RegisteredNot determinedNone
Momate ointment

EACH 1,0 g OINTMENT CONTAINS MOMETASONE FUROATE 1,0 mg

Ointment44009544/21.5.1/0095RegisteredNot determinedNone
Mometasone sandoz nasal spray

EACH ACTUATION CONTAINS MOMETASONE FUROATE 50,0 ug

Spray46049046/21.5.1/0490RegisteredNot determinedNone
Zilfone nasal spray

EACH ACTUATION CONTAINS MOMETASONE FUROATE 50,0 ug

Spray460491.4946/21.5.1/0491.490RegisteredNot determinedNone
Monact

Each metered actuation contains: Mometasone Furoate monohydrate equivalent to mometasone Furoate 50,0 ug

Not listed47122347/21.5.1/1223RegisteredNot determinedNone
Naxal aqueous nasal spray

EACH METERED DOSE PUMP ACTUATION CONTAINS: MOMETASONE FUROATE MONOHYDRATE EQUIVALENT TO MOMETASONE FUROATE ANHYDROUS 50,0 mcg

Spray51000551/21.5.1/0005CancelledNot determinedNone
Momagex

EACH ACTUATION CONTAINS MOMETASONE FUROATE MONOHYDRATE 50,0 µg

Not listed53016753/21.5/0167RegisteredNot determinedNone
Mometasone adco

EACH ACTUATION CONTAINS MOMETASONE FUROATE MONOHYDRATE 50,0 µg

Not listed530168.16753/21.5/0168.167RegisteredNot determinedNone
Mometasone 50 μg glenmark

EACH SUSPENSION CONTAINS MOMETASONE FUROATE 50,0 μg

50 μg53061453/21.5.1/0614RegisteredNot determinedNone
Nexomist

EACH ACTUATION CONTAINS MOMETASONE FUROATE 50,0 ug

Not listedA380341A38/21.5.1/0341RegisteredNot determinedNone
Nasomist

EACH METERED SPRAY CONTAINS MOMETASONE FUROATE 50,0 ug

Not listedA380342A38/21.5.1/0342CancelledNot determinedNone
Aspen mometasone cream

EACH 1,0.g CREAM CONTAINS MOMETASONE FUROATE 1,0 mg

1,0 mg/1,0 gCreamA380668A38/13.4.1/0668Approved 4 April 2024RegisteredS4PIPIL
Mometagen 0,1 %

EACH 1,0 g CREAM CONTAINS MOMETASONE FUROATE 1,0 mg

0,1 %A400666A40/13.4.1/0666CancelledNot determinedNone
Elocon cream

1 G MOMETASONE FUROATE 1 MG

CreamV0272V/13.4.1/272RegisteredNot determinedNone
Elocon ointment

EACH 1 g OINTMENT CONTAINS MOMETASONE FUROATE 1 mg

OintmentV0273V/13.4.1/273RegisteredNot determinedNone
Elocon lotion

1 G MOMETASONE FUROATE 1 MG

LotionX0266X/13.4.1/266RegisteredNot determinedNone

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Mometasone furoate

  • S4: Mometasone furoate

    • except when intended for inhalation or nasal administration.

    Consolidated Schedules 06 July 2026, line 7167

  • S3: Mometasone furoate

    • when intended for inhalation or nasal administration, except when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
    • a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
    • a maximum pack size of 200 doses. (S2, S4)

    Consolidated Schedules 06 July 2026, lines 3960 to 3965

  • S2: Mometasone furoate

    • when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
    • a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
    • a maximum pack size of 200 doses. (S3, S4)

    Consolidated Schedules 06 July 2026, lines 2284 to 2290

Pharmacological class: Corticosteroids with or without anti-infective agents. (class 13.4.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsNasonex, Organon South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersNasonex, Organon South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles